Asymptomatic coronary artery disease in chagasic patients with heart failure: prevalence and risk factors

Gustavo Carvalho1, Salvador Rassi, José Maria Dias de Azeredo Bastos

  • 1Hospital das Clínicas, Universidade Federal de Goiás, Goiânia, GO, Brazil. gustavocarvalho@cardiol.br

Insights

The prevalence of asymptomatic coronary artery disease in patients with Chagas cardiomyopathy and severe heart failure is low (1.6%). Smoking was the most common risk factor identified in this population.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • Chagas cardiomyopathy and coronary artery disease are prevalent in Brazil.
  • The coexistence of asymptomatic coronary artery disease in Chagas cardiomyopathy patients with heart failure is debated.

Purpose of the Study:

  • To determine the prevalence of significant coronary artery disease (>50% lesions) in Chagas cardiomyopathy patients with heart failure (HF) functional class III/IV.
  • To assess risk factors for atherosclerosis in this specific patient cohort.

Main Methods:

  • Coronary angiography was performed on 61 consecutive Chagas cardiomyopathy patients (HF functional class III/IV) prior to stem cell therapy.
  • Risk factors for atherosclerosis including age, hypertension, diabetes, dyslipidemia, smoking, and overweight were analyzed.

Main Results:

  • The prevalence of coronary artery disease was low at 1.6% (1 patient).
  • Prevalent risk factors included smoking (59%), arterial hypertension (18%), dyslipidemia (6.5%), and diabetes (1.6%).

Conclusions:

  • Asymptomatic coronary artery disease is uncommon in patients with severe Chagas heart failure.
  • Smoking emerged as the most frequent coronary heart disease risk factor in this population.
Abstract

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...